HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Influence of cholesteryl ester transfer protein, peroxisome proliferator-activated receptor alpha, apolipoprotein E, and apolipoprotein A-I polymorphisms on high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I:A-II concentrations: the Prospective Epidemiological Study of Myocardial Infarction study.

Abstract
The plasma level of high-density lipoprotein cholesterol (HDL-C) is known to be inversely associated with cardiovascular risk. However, besides lifestyle, gene polymorphism may influence the HDL-C concentration. The aim of this study was to investigate the possibility of interactions between CETP, PPARA, APOE, and APOAI polymorphisms and HDL-C, apolipoprotein (apo) A-I, lipoprotein (Lp) A-I, and Lp A-I:A-II in a sample selected from the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study population who remained free of cardiovascular events over 5 years of follow-up. Healthy individuals (857) were randomly selected for genotyping the PRIME study subjects. The population was selected so as to provide 25% of subjects in the lowest tertile of HDL-C (< or = 28 mg/dL) in the whole PRIME study sample, 25% of subjects in the highest tertile of HDL-C (> or = 73 mg/dL), and 50% of subjects in the medium tertile of HDL-C (28-73 mg/dL). Genotyping was performed by using a polymerase chain reaction system with predeveloped TaqMan allelic discrimination assay. The CETP A373P rare allele c was less frequent in the group of subjects with high HDL-C, apo A-I, Lp A-I, and Lp A-I:A-II concentrations. Apolipoprotein A-I and Lp A-I were also found to be higher in the presence of the epsilon2 allele coding for APOE. The effect of the CETP A373P rare allele c on HDL-C was independent of all tested parameters except triglycerides. The respective effect of these polymorphisms and triglycerides on cardiovascular risk should be evaluated prospectively.
AuthorsHong Quang Do, Hassan Nazih, Gérald Luc, Dominique Arveiler, Jean Ferrières, Alun Evans, Philippe Amouyel, François Cambien, Pierre Ducimetière, Jean-Marie Bard
JournalMetabolism: clinical and experimental (Metabolism) Vol. 58 Issue 3 Pg. 283-9 (Mar 2009) ISSN: 1532-8600 [Electronic] United States
PMID19217440 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Apolipoprotein A-I
  • Apolipoprotein A-II
  • Apolipoproteins E
  • Cholesterol Ester Transfer Proteins
  • Cholesterol, HDL
  • PPAR alpha
  • DNA
Topics
  • Apolipoprotein A-I (blood, genetics)
  • Apolipoprotein A-II (blood)
  • Apolipoproteins E (genetics)
  • Cholesterol Ester Transfer Proteins (genetics)
  • Cholesterol, HDL (blood)
  • Cohort Studies
  • DNA (blood, genetics)
  • France
  • Genotype
  • Humans
  • Life Style
  • Male
  • Middle Aged
  • Myocardial Infarction (blood, epidemiology, genetics)
  • Northern Ireland
  • PPAR alpha (genetics)
  • Polymorphism, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: